Click for best price
Ophthalmic Therapeutic Drugs Market Size, Share 2022
This report contains market size and forecasts of Ophthalmic Therapeutic Drugs in Global, including the following market information:
Global Ophthalmic Therapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ophthalmic Therapeutic Drugs market was valued at 16710 million in 2021 and is projected to reach US$ 23470 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-inflammatory Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Therapeutic Drugs include Bayer, Pfizer, Novartis, ALLERGAN, Aerie Pharmaceuticals, Bausch Health, Genentech, Regeneron Pharmaceuticals and Takeda and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ophthalmic Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Therapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ophthalmic Therapeutic Drugs Market Segment Percentages, by Type, 2021 (%)
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
Global Ophthalmic Therapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ophthalmic Therapeutic Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Global Ophthalmic Therapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ophthalmic Therapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Therapeutic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ophthalmic Therapeutic Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Bausch Health
Genentech
Regeneron Pharmaceuticals
Takeda
Santen Pharmaceutical
| Report Attributes |
Report Details |
| Report Title |
Ophthalmic Therapeutic Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Therapeutic Drugs Overall Market Size
2.1 Global Ophthalmic Therapeutic Drugs Market Size: 2021 VS 2028
2.2 Global Ophthalmic Therapeutic Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ophthalmic Therapeutic Drugs Players in Global Market
3.2 Top Global Ophthalmic Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Ophthalmic Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Ophthalmic Therapeutic Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ophthalmic Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ophthalmic Therapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Ophthalmic Therapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Ophthalmic Therapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Ophthalmic Therapeutic Drugs Market Size Markets, 2021 & 2028
4.1.2 Anti-inflammatory Drugs
4.1.3 Anti-infective Drugs
4.1.4 Anti-glaucoma Drugs
4.1.5 Anti-allergy Drugs
4.1.6 Anti-VEGF Agents
4.1.7 Others
4.2 By Type - Global Ophthalmic Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global Ophthalmic Therapeutic Drugs Revenue, 2017-2022
4.2.2 By Type - Global Ophthalmic Therapeutic Drugs Revenue, 2023-2028
4.2.3 By Type - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmic Therapeutic Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Independent Pharmacies & Drug Stores
5.2 By Application - Global Ophthalmic Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global Ophthalmic Therapeutic Drugs Revenue, 2017-2022
5.2.2 By Application - Global Ophthalmic Therapeutic Drugs Revenue, 2023-2028
5.2.3 By Application - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Ophthalmic Therapeutic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Ophthalmic Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global Ophthalmic Therapeutic Drugs Revenue, 2017-2022
6.2.2 By Region - Global Ophthalmic Therapeutic Drugs Revenue, 2023-2028
6.2.3 By Region - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Ophthalmic Therapeutic Drugs Revenue, 2017-2028
6.3.2 US Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.3.3 Canada Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.3.4 Mexico Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Ophthalmic Therapeutic Drugs Revenue, 2017-2028
6.4.2 Germany Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.4.3 France Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.4.4 U.K. Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.4.5 Italy Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.4.6 Russia Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.4.8 Benelux Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Ophthalmic Therapeutic Drugs Revenue, 2017-2028
6.5.2 China Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.5.3 Japan Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.5.4 South Korea Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.5.6 India Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Ophthalmic Therapeutic Drugs Revenue, 2017-2028
6.6.2 Brazil Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.6.3 Argentina Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ophthalmic Therapeutic Drugs Revenue, 2017-2028
6.7.2 Turkey Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.7.3 Israel Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Ophthalmic Therapeutic Drugs Market Size, 2017-2028
6.7.5 UAE Ophthalmic Therapeutic Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Ophthalmic Therapeutic Drugs Major Product Offerings
7.1.4 Bayer Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.1.5 Bayer Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Ophthalmic Therapeutic Drugs Major Product Offerings
7.2.4 Pfizer Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Ophthalmic Therapeutic Drugs Major Product Offerings
7.3.4 Novartis Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 ALLERGAN
7.4.1 ALLERGAN Corporate Summary
7.4.2 ALLERGAN Business Overview
7.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Major Product Offerings
7.4.4 ALLERGAN Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.4.5 ALLERGAN Key News
7.5 Aerie Pharmaceuticals
7.5.1 Aerie Pharmaceuticals Corporate Summary
7.5.2 Aerie Pharmaceuticals Business Overview
7.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Major Product Offerings
7.5.4 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.5.5 Aerie Pharmaceuticals Key News
7.6 Bausch Health
7.6.1 Bausch Health Corporate Summary
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Ophthalmic Therapeutic Drugs Major Product Offerings
7.6.4 Bausch Health Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.6.5 Bausch Health Key News
7.7 Genentech
7.7.1 Genentech Corporate Summary
7.7.2 Genentech Business Overview
7.7.3 Genentech Ophthalmic Therapeutic Drugs Major Product Offerings
7.7.4 Genentech Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.7.5 Genentech Key News
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Corporate Summary
7.8.2 Regeneron Pharmaceuticals Business Overview
7.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Major Product Offerings
7.8.4 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.8.5 Regeneron Pharmaceuticals Key News
7.9 Takeda
7.9.1 Takeda Corporate Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Ophthalmic Therapeutic Drugs Major Product Offerings
7.9.4 Takeda Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.9.5 Takeda Key News
7.10 Santen Pharmaceutical
7.10.1 Santen Pharmaceutical Corporate Summary
7.10.2 Santen Pharmaceutical Business Overview
7.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Major Product Offerings
7.10.4 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue in Global Market (2017-2022)
7.10.5 Santen Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ophthalmic Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Ophthalmic Therapeutic Drugs Market Drivers in Global Market
Table 3. Ophthalmic Therapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Ophthalmic Therapeutic Drugs in Global Market
Table 5. Top Ophthalmic Therapeutic Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ophthalmic Therapeutic Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ophthalmic Therapeutic Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ophthalmic Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 Ophthalmic Therapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Therapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ophthalmic Therapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ophthalmic Therapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ophthalmic Therapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ophthalmic Therapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ophthalmic Therapeutic Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ophthalmic Therapeutic Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Ophthalmic Therapeutic Drugs Product Offerings
Table 32. Bayer Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Ophthalmic Therapeutic Drugs Product Offerings
Table 35. Pfizer Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Ophthalmic Therapeutic Drugs Product Offerings
Table 38. Novartis Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 39. ALLERGAN Corporate Summary
Table 40. ALLERGAN Ophthalmic Therapeutic Drugs Product Offerings
Table 41. ALLERGAN Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Aerie Pharmaceuticals Corporate Summary
Table 43. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product Offerings
Table 44. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Bausch Health Corporate Summary
Table 46. Bausch Health Ophthalmic Therapeutic Drugs Product Offerings
Table 47. Bausch Health Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Genentech Corporate Summary
Table 49. Genentech Ophthalmic Therapeutic Drugs Product Offerings
Table 50. Genentech Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Regeneron Pharmaceuticals Corporate Summary
Table 52. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Product Offerings
Table 53. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Takeda Corporate Summary
Table 55. Takeda Ophthalmic Therapeutic Drugs Product Offerings
Table 56. Takeda Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Santen Pharmaceutical Corporate Summary
Table 58. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product Offerings
Table 59. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Ophthalmic Therapeutic Drugs Segment by Type in 2021
Figure 2. Ophthalmic Therapeutic Drugs Segment by Application in 2021
Figure 3. Global Ophthalmic Therapeutic Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Therapeutic Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ophthalmic Therapeutic Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ophthalmic Therapeutic Drugs Revenue in 2021
Figure 8. By Type - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 12. US Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 24. China Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ophthalmic Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ALLERGAN Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch Health Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genentech Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Takeda Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
